{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:30Z","timestamp":1707525630543},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,20]]},"DOI":"10.7759\/cureus.50839","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T15:00:31Z","timestamp":1703084431000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case Report of Follicular Lymphoma in a Crohn\u2019s Disease Patient Treated With Azathioprine"],"prefix":"10.7759","author":[{"given":"Nadeer","family":"Kottavadakkeel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reefat","family":"Farzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathia","family":"Mannath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abida","family":"Sunil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)90402-x","article-title":"Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine","volume":"27","author":"Bouhnik Y","year":"1996","unstructured":"Bouhnik Y, L\u00e9mann M, Mary JY, et al.. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet. 1996, 27:215-19. 10.1016\/s0140-6736(96)90402-x","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28703","article-title":"Inflammatory bowel disease is not associated with an increased risk of lymphoma","volume":"121","author":"Lewis JD","year":"2001","unstructured":"Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology. 2001, 121:1080-7. 10.1053\/gast.2001.28703","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein CN","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001, 91:4-854. 10.1002\/1097-0142(20010215)91:4&lt;854::aid-cncr1073&gt;3.0.co;2-z","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.053231","article-title":"Risks and benefits of azathioprine therapy","volume":"54","author":"McGovern DP","year":"2005","unstructured":"McGovern DP, Jewell DP. Risks and benefits of azathioprine therapy. Gut. 2005, 54:1055-9. 10.1136\/gut.2004.053231","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.04.001","article-title":"Increasing risk of lymphoma over time in Crohn\u2019s disease but not in ulcerative colitis: a Scandinavian cohort study","volume":"21","author":"Ol\u00e9n O","year":"2023","unstructured":"Ol\u00e9n O, Smedby KE, Erichsen R, et al.. Increasing risk of lymphoma over time in Crohn\u2019s disease but not in ulcerative colitis: a Scandinavian cohort study. Clin Gastroenterol Hepatol. 2023, 21:3132-42. 10.1016\/j.cgh.2023.04.001","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie L","year":"2009","unstructured":"Beaugerie L, Brousse N, Bouvier AM, et al.. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009, 374:1617-25. 10.1016\/S0140-6736(09)61302-7","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.07.035","article-title":"Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study","volume":"145","author":"Khan N","year":"2013","unstructured":"Khan N, Abbas AM, Lichtenstein GR, Loftus EV Jr, Bazzano LA. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. Gastroenterology. 2013, 145:1007-15.e3. 10.1053\/j.gastro.2013.07.035","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.05.015","article-title":"Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis","volume":"13","author":"Kotlyar DS","year":"2015","unstructured":"Kotlyar DS, Lewis JD, Beaugerie L, et al.. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015, 13:847-58.e4; quiz e48-50. 10.1016\/j.cgh.2014.05.015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2023-0082","article-title":"A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report","volume":"9","author":"Merhaben S","year":"2023","unstructured":"Merhaben S, Ayadi S, Tangour M, Boujelbene N, Ghariani R, Mouelhi L, Merhaben F. A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report. Future Sci OA. 2023, 9:FSO893. 10.2144\/fsoa-2023-0082","journal-title":"Future Sci OA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1683923","article-title":"Crohn's disease and the risk of cancer","volume":"32","author":"Carchman E","year":"2019","unstructured":"Carchman E. Crohn's disease and the risk of cancer. Clin Colon Rectal Surg. 2019, 32:305-13. 10.1055\/s-0039-1683923","journal-title":"Clin Colon Rectal Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies","volume":"105","author":"Pedersen N","year":"2010","unstructured":"Pedersen N, Duricova D, Elkjaer M, Gamborg M, Munkholm P, Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010, 105:1480-7. 10.1038\/ajg.2009.760","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0451","article-title":"Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease","volume":"69","author":"Nguyen T","year":"2009","unstructured":"Nguyen T, Vacek PM, O'Neill P, Colletti RB, Finette BA. Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease. Cancer Res. 2009, 69:7004-12. 10.1158\/0008-5472.CAN-09-0451","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19990915)86:6<1080::aid-cncr26>3.0.co;2-5","article-title":"Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism","volume":"86","author":"Bo J","year":"1999","unstructured":"Bo J, Schr\u00f8der H, Kristinsson J, et al.. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism. Cancer. 1999, 86:1080-6. 10.1002\/(sici)1097-0142(19990915)86:6&lt;1080::aid-cncr26&gt;3.0.co;2-5","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar DS","year":"2011","unstructured":"Kotlyar DS, Osterman MT, Diamond RH, et al.. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011, 9:36-41.e1. 10.1016\/j.cgh.2010.09.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198009000-00003","article-title":"Acute myelogenous leukemia in patients with ulcerative colitis","volume":"2","author":"Fabry TL","year":"1980","unstructured":"Fabry TL, Sachar DB, Janowitz HD. Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol. 1980, 2:225-7. 10.1097\/00004836-198009000-00003","journal-title":"J Clin Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198510000-00002","article-title":"Colonic lymphoma in ulcerative colitis","volume":"7","author":"Baker D","year":"1985","unstructured":"Baker D, Chiprut RO, Rimer D, Lewin KJ, Rosenberg MZ. Colonic lymphoma in ulcerative colitis. J Clin Gastroenterol. 1985, 7:379-86. 10.1097\/00004836-198510000-00002","journal-title":"J Clin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz G","year":"1993","unstructured":"Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993, 342:1514-16. 10.1016\/s0140-6736(05)80084-4","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa193","article-title":"Characteristics of lymphoma in patients with inflammatory bowel disease: a systematic review","volume":"15","author":"Muller M","year":"2021","unstructured":"Muller M, Bros\u00e9us J, Feugier P, et al.. Characteristics of lymphoma in patients with inflammatory bowel disease: a systematic review. J Crohns Colitis. 2021, 15:827-39. 10.1093\/ecco-jcc\/jjaa193","journal-title":"J Crohns Colitis"},{"key":"ref19","article-title":"Follicular lymphoma","author":"Kaseb H","year":"2023","unstructured":"Kaseb H, Ali MA, Koshy NV. Follicular lymphoma. StatPearls. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref20","article-title":"6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come","volume":"91","author":"Peppercom MA","year":"1996","unstructured":"Peppercom MA. 6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come. Am J Gastroenterol. 1996, 91:1689-90.","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211029-a-case-report-of-follicular-lymphoma-in-a-crohns-disease-patient-treated-with-azathioprine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:26Z","timestamp":1707509426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211029-a-case-report-of-follicular-lymphoma-in-a-crohns-disease-patient-treated-with-azathioprine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.50839","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,20]]}}}